These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30584005)

  • 41. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 42. Statin-induced myopathy.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(3):156-7. PubMed ID: 18568178
    [No Abstract]   [Full Text] [Related]  

  • 43. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.
    Halbert SC; French B; Gordon RY; Farrar JT; Schmitz K; Morris PB; Thompson PD; Rader DJ; Becker DJ
    Am J Cardiol; 2010 Jan; 105(2):198-204. PubMed ID: 20102918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin-induced myopathy: the two faces of Janus.
    Arora R; Liebo M; Maldonado F
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perioperative chronic use of statins and the risk of muscle complaints in patients undergoing knee and hip endoprosthesis surgery.
    Laisalmi-Kokki M; Tolonen K; Miettinen H; Kokki H
    J Clin Anesth; 2010 Mar; 22(2):81-7. PubMed ID: 20304347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries.
    Rosenson RS; Gandra SR; McKendrick J; Dent R; Wieffer H; Cheng LI; Catapano AL; Oh P; Kees Hovingh G; Stroes ES
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):187-195. PubMed ID: 28466399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G; Spatz ES; Jablecki C; Phillips PS
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
    Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
    J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
    Whayne TF
    Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?
    Muntean DM; Thompson PD; Catapano AL; Stasiolek M; Fabis J; Muntner P; Serban MC; Banach M
    Drug Discov Today; 2017 Jan; 22(1):85-96. PubMed ID: 27634340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Statin Intolerance in 2018: Still More Questions Than Answers.
    Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of statins in patients with liver disease.
    Kalaitzakis E; Björnsson ES
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):15-24. PubMed ID: 24632765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
    Taylor BA; Thompson PD
    Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin-related myotoxicity.
    Fernandes V; Santos MJ; Pérez A
    Endocrinol Nutr; 2016 May; 63(5):239-49. PubMed ID: 27005745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis.
    Irwin JC; Khalesi S; Fenning AS; Vella RK
    Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.